News About: Pharm. Industry
Dong-A sales rise, operating profits drop
Stimulated by robust Bacchus-F, OTC version of popular Bacchus-D drink, Dong-A Pharmaceutical posted 241.9 billion won in revenue for the July-Sept. period, up a 14 percent increase from 212.1 billion won last year.
...
Impact of KORUS FTA on pharmaceutical industry
President Lee Myung Park sent a letter to all lawmakers Thursday, urging them to pass the long-pending Korea-U.S. free trade agreement (KORUS FTA) within October.
The KORUS FTA was originally signed in 2007 to boos...
Korean drugmakers doomed to become sales agents of multinational firms
Pharmaceutical companies warned that the government’s plan to cut drug prices by an average of 17 percent starting next year will open the door for foreign dominance of domestic pharmaceutical sector.
Local players...
Returned goods headache in pharmaceutical industry
The government needs to deal with returned goods in pharmacy as retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government-led reforms, market observers said....
Concerns mounting over KORUS FTA bill
The U.S. Congress finally ratified the Korea-United States free trade agreement, demonstrating America’s commitment to upgrading and expanding the long-standing military alliance between the two countries to encompass...
KPMA seeking to suspend temporary production of pharmaceuticals
The Korea Pharmaceutical Manufacturers Association said Wednesday that after heated discussion, it has decided to discontinue the short-term production of drugs as well as other countermeasures as part of efforts to p...
Drug pricing reform should be predictable
The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharmaceutical R&D investment is very long-term and carries a significant...
Policies need to provide better environment for good pharmaceutical firms
The amended law has made doctors and pharmacists as well as pharmaceutical firms subject to punishment if they are found to have been involved in illegal deals. Policymakers hoped this dual punishment clause would red...
Pharmaceutical firms eyes OTC drugs
Domestic drug firms are seeking a breakthrough in their sluggish ethical business by entering more promising over-the-counter (OTC) market as they believe it will create more profits.
Chong Kun Dang Pharmaceutical...
Most firms still sweating over 2012 sales and marketing plans
A majority of sales and marketing executives in domestic pharmaceutical firms are still struggling to finalize their plans for the new year.
The government’s plan to cut drug prices by an average of 17 percent star...
